Leonid Katz

2.4k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Leonid Katz is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Leonid Katz has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Oncology. Recurrent topics in Leonid Katz's work include Diabetes Treatment and Management (5 papers), Diabetes Management and Research (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Leonid Katz is often cited by papers focused on Diabetes Treatment and Management (5 papers), Diabetes Management and Research (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Leonid Katz collaborates with scholars based in United States, Denmark and Spain. Leonid Katz's co-authors include Bente Langdahl, Adolfo Díez‐Pérez, Michael R. McClung, Steven Boonen, Jacques P. Brown, Scott M. Wasserman, Jean‐Yves Reginster, Cesar Libanati, José Zanchetta and Andreas Grauer and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Leonid Katz

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

2014 886 citations Michael R. McClung, Andreas Grauer et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leonid Katz United States	12	773	622	551	550	413	18	1.7k
Ho Yeon Chung South Korea	22	518 0.7×	422 0.7×	476 0.9×	353 0.6×	258 0.6×	73	1.8k
Pedro Rozas-Moreno Spain	13	376 0.5×	203 0.3×	370 0.7×	190 0.3×	88 0.2×	32	879
Alexander Sattler Germany	13	404 0.5×	222 0.4×	177 0.3×	192 0.3×	164 0.4×	27	918
P. Clifton‐Bligh Australia	21	201 0.3×	227 0.4×	142 0.3×	330 0.6×	332 0.8×	54	1.1k
G Crepaldi Italy	15	200 0.3×	450 0.7×	352 0.6×	104 0.2×	135 0.3×	25	947
Jing Liang China	18	295 0.4×	258 0.4×	60 0.1×	164 0.3×	181 0.4×	73	1.0k
Dong Jun Lim South Korea	22	222 0.3×	123 0.2×	48 0.1×	853 1.6×	501 1.2×	67	1.4k
Yuichi Takashi Japan	18	313 0.4×	157 0.3×	71 0.1×	217 0.4×	115 0.3×	51	890
Philipp Rein Austria	21	266 0.3×	129 0.2×	32 0.1×	219 0.4×	300 0.7×	69	1.3k
George Christodoulakos Greece	21	135 0.2×	173 0.3×	98 0.2×	384 0.7×	90 0.2×	55	1.3k

Countries citing papers authored by Leonid Katz

Since Specialization

Citations

This map shows the geographic impact of Leonid Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Katz more than expected).

Fields of papers citing papers by Leonid Katz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Katz. The network helps show where Leonid Katz may publish in the future.

Co-authorship network of co-authors of Leonid Katz

This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Katz. A scholar is included among the top collaborators of Leonid Katz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Katz. Leonid Katz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations

Masri, Ahmad, Mandar A. Aras, Daniel Jacoby, et al.. (2025). Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up. Journal of Cardiac Failure. 31(8). 1354–1359. 2 indexed citations

Masri, Ahmad, Mandar A. Aras, Rodney H. Falk, et al.. (2022). LONG-TERM SAFETY AND TOLERABILITY OF ACORAMIDIS (AG10) IN SYMPTOMATIC TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: UPDATED ANALYSIS FROM AN ONGOING PHASE 2 OPEN-LABEL EXTENSION STUDY. Journal of the American College of Cardiology. 79(9). 227–227. 2 indexed citations

Gillmore, Julian D., Pablo García‐Pavía, Martha Grogan, et al.. (2019). Abstract 14214: ATTRibute-CM: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Phase 3 Study of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Circulation. 5 indexed citations

McClung, Michael R., Andreas Grauer, Steven Boonen, et al.. (2014). Romosozumab in Postmenopausal Women with Low Bone Mineral Density. New England Journal of Medicine. 370(5). 412–420. 886 indexed citations breakdown →

Xue, Fei, Haijun Ma, Catherine Stehman‐Breen, et al.. (2013). Design and methods of a postmarketing pharmacoepidemiology study assessing long‐term safety of Prolia^® (denosumab) for the treatment of postmenopausal osteoporosis. Pharmacoepidemiology and Drug Safety. 22(10). 1107–1114. 20 indexed citations

McClung, Michael R., Andreas Grauer, Steven Boonen, et al.. (2013). OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results. Annals of the Rheumatic Diseases. 72. A136–A137. 5 indexed citations

Goessl, Carsten, Leonid Katz, William C. Dougall, et al.. (2012). The development of denosumab for the treatment of diseases of bone loss and cancer‐induced bone destruction. Annals of the New York Academy of Sciences. 1263(1). 29–40. 30 indexed citations

Katz, Leonid, Paul Rothenberg, Nicole Vaccaro, et al.. (2012). Effects of JNJ‐38431055, a novel GPR119 receptor agonist, in randomized, double‐blind, placebo‐controlled studies in subjects with type 2 diabetes. Diabetes Obesity and Metabolism. 14(8). 709–716. 92 indexed citations

10.

Girman, Cynthia J., Tzuyung D. Kou, Kimberly G. Brodovicz, et al.. (2011). Risk of acute renal failure in patients with Type 2 diabetes mellitus. Diabetic Medicine. 29(5). 614–621. 67 indexed citations

11.

Wainstein, Julio, Leonid Katz, Samuel S. Engel, et al.. (2011). Initial therapy with the fixed‐dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 14(5). 409–418. 40 indexed citations

12.

Katz, Leonid, Paul Rothenberg, Nicole Vaccaro, et al.. (2011). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects. Clinical Pharmacology & Therapeutics. 90(5). 685–692. 37 indexed citations

13.

Girman, Cynthia J., Tzuyung D. Kou, Charles M. Alexander, et al.. (2010). Patients with type 2 diabetes mellitus have higher risk for acute pancreatitis compared with those without diabetes. Diabetes Obesity and Metabolism. 12(9). 766–771. 161 indexed citations

14.

Cai, Beilei, Leonid Katz, Charles M. Alexander, Debora Williams‐Herman, & Cynthia J. Girman. (2010). Characteristics of patients prescribed sitagliptin and other oral antihyperglycaemic agents in a large US claims database. International Journal of Clinical Practice. 64(12). 1601–1608. 16 indexed citations

15.

Vilsbøll, Tina, Julio Rosenstock, H Yki-Järvinen, et al.. (2009). Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 12(2). 167–177. 253 indexed citations

16.

Hay, Emile, et al.. (2002). Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet. Journal of Emergency Medicine. 22(4). 349–352. 21 indexed citations

17.

Katz, Leonid, et al.. (1984). Characterization of the enhanced paw edema response to carrageenan and dextran in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.. Journal of Pharmacology and Experimental Therapeutics. 230(3). 670–677. 23 indexed citations

18.

Theobald, Holger, Robert W. Moore, Leonid Katz, R Pieper, & Ralph E. Peterson. (1983). Enhancement of carrageenan and dextran-induced edemas by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds.. Journal of Pharmacology and Experimental Therapeutics. 225(3). 576–583. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact